Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.063
Sell
RSI(14)
47.033
Neutral
STOCH(KDJ)(9,3,3)
24.458
Neutral
ATR(14)
0.517
High Vlolatility
CCI(14)
-53.522
Neutral
Williams %R
70.792
Sell
TRIX(12,20)
-0.137
Sell
StochRSI(14)
100.000
Buy
Avanos Medical Inc
AVNS11.230USD
+0.055+0.49%
Close 11/07, 16:00（ET）Quotes delayed by 15 min
521.26MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Avanos Medical Inc
Currency: USD Updated: 2025-11-07Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Avanos Medical Inc's Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
1
analysts
Hold
Current Rating
14.000
Target Price
+13.73%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Avanos Medical Inc Highlights
StrengthsRisks
Avanos Medical, Inc. is a medical device company, which is focused on delivering solutions. The Company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Company conducts its business in one segment that provides its medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. The Company’s acute pain products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. The Company's interventional pain solutions include COOLIEF pain therapy and OrthogenRxs knee osteoarthritis pain relief injection products.
Fairly Valued
The company’s latest PE is -1.10, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 41.71M shares, decreasing 17.77% quarter-over-quarter.
Held by Barrow Hanley
Star Investor Barrow Hanley holds 624.00 shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.26.
Financial Health
Currency: USD Updated: 2025-11-07The company's current financial score is 7.79, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 177.80M, representing a year-over-year increase of 4.34%, while its net profit experienced a year-over-year increase of 132.56%.
Score
Financials
8.86
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
6.50
Operational Efficiency
8.81
Growth Potential
7.55
Shareholder Returns
7.25
Avanos Medical Inc's Company Valuation
Currency: USD Updated: 2025-11-07The company’s current valuation score is 9.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -1.10, which is -13895.35% below the recent high of 152.14 and -2995.84% above the recent low of -34.14.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 80/209
No Data
Earnings Forecast
Currency: USD Updated: 2025-11-07The company’s current earnings forecast score is 6.00, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Avanos Medical Inc is 14.00, with a high of 14.00 and a low of 14.00.
Score
Support & Resistance
No Data
Analyst Rating
Based on
1
analysts
Hold
Current Rating
14.000
Target Price
+13.73%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
110
Total
7
Median
9
Average
Company name
Ratings
Analysts
Avanos Medical Inc
AVNS
1
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
32
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
30
1
2
3
...
22
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-11-07The company’s current price momentum score is 6.66, which is lower than the Healthcare Equipment & Supplies industry's average of 6.88. Sideways: Currently, the stock price is trading between the resistance level at 12.38 and the support level at 10.36, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
11.114
Buy
MA10
11.253
Sell
MA20
11.368
Sell
MA50
11.681
Sell
MA100
11.652
Sell
MA200
12.819
Sell
Institutional Confidence
Currency: USD Updated: 2025-11-07The company’s current institutional recognition score is 7.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.42. The latest institutional shareholding proportion is 89.88%, representing a quarter-over-quarter decrease of 8.01%. The largest institutional shareholder is The Vanguard, holding a total of 3.43M shares, representing 7.38% of shares outstanding, with 36.15% decrease in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Investment Management, Inc.
Dimensional Fund Advisors, L.P.
Armistice Capital LLC
State Street Investment Management (US)
Brown Advisory
ExodusPoint Capital Management, LP
D. E. Shaw & Co., L.P.
Geode Capital Management, L.L.C.
1
2
Risk Assessment
Currency: USD Updated: 2025-11-07The company’s current risk assessment score is 5.60, which is higher than the Healthcare Equipment & Supplies industry's average of 4.58. The company's beta value is 1.09. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
1.09
VaR
+3.48%
240-Day Maximum Drawdown
+49.54%
240-Day Volatility
+42.96%
Return
Best Daily Return
60 days
+4.93%
120 days
+4.93%
5 years
+13.24%
Worst Daily Return
60 days
-5.66%
120 days
-12.09%
5 years
-17.90%
Sharpe Ratio
60 days
+0.68
120 days
-0.62
5 years
-0.61
Risk Assessment
Maximum Drawdown
240 days
+49.54%
3 years
+68.85%
5 years
+81.46%
Return-to-Drawdown Ratio
240 days
-0.76
3 years
-0.28
5 years
-0.18
Skewness
240 days
-0.32
3 years
-1.26
5 years
-0.86
Volatility
Realised Volatility
240 days
+42.96%
5 years
+39.35%
Standardised True Range
240 days
+4.31%
5 years
+7.16%
Downside Risk-Adjusted Return
120 days
-81.30%
240 days
-81.30%
Maximum Daily Upside Volatility
60 days
+32.77%
Maximum Daily Downside Volatility
60 days
+23.58%
Liquidity
Average Turnover Rate
60 days
+1.22%
120 days
+1.16%
5 years
--
Turnover Deviation
20 days
+125.91%
60 days
+57.58%
120 days
+50.46%
Peer Comparison
Healthcare Equipment & Supplies
Avanos Medical Inc
AVNS
7.09 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
CSTL
8.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
COR
8.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
TCMD
8.60 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STE
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AXGN
8.53 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
